Daniel Janney's Net Worth

$440 Million

Estimate Recalculated Mar 1, 2024 08:20PM EST

Who is Daniel Janney?

Daniel Janney has an estimated net worth of $440 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., ZS Pharma, Inc., SUTRO BIOPHARMA, INC., TREVENA INC, APPLIED GENETIC TECHNOLOGIES CORP, aTYR PHARMA INC, Neothetics, Inc., ANESIVA, INC., ATS MEDICAL INC, RENOVIS INC, Allakos Inc., CUTERA INC, DYNAVAX TECHNOLOGIES CORP, NeurogesX Inc, ACELRX PHARMACEUTICALS INC, ICAGEN INC, FLAMEL TECHNOLOGIES SA, INTARCIA THERAPEUTICS, INC, TorreyPines Therapeutics, Inc., OCCAM NETWORKS INC/DE, COTHERIX INC, Krystal Biotech, Inc., Tyra Biosciences, Inc., Carbylan Therapeutics, Inc., Esperion Therapeutics, Inc., AERIE PHARMACEUTICALS INC, VIVEVE MEDICAL, INC., and ELLIE MAE INC.

SEC CIK

Daniel Janney's CIK is 0001198325

Past Insider Trading and Trends

2014 was Daniel Janney's most active year for acquiring shares with 27 total transactions. Daniel Janney's most active month to acquire stocks was the month of January. 2014 was Daniel Janney's most active year for disposing of shares, totalling 27 transactions. Daniel Janney's most active month to dispose stocks was the month of January. 2014 saw Daniel Janney paying a total of $28,496,905.70 for 16,804,389 shares, this is the most they've acquired in one year. In 2003 Daniel Janney cashed out on 3,325,000 shares for a total of $63,177,849.99, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNE DESIGN CORP. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.48M
$12.00
2.48M
Jul 29
Form 3
0
0
No matching records found

OCCAM NETWORKS INC/DE No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.63M
1.63M
Nov 7
Form 4
0
0
Apr 20
Form 4
0
0
Mar 23
Form 4
0
0
Jan 7
Form 3
0
0
No matching records found

COTHERIX INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.95M
$13.50
-$39,876,111.00
0
Jan 9
Form 4
-100.00%
-2.95M
$13.50
-$39,876,111.00
0
Jan 9
Form 4
0
0
Jan 3
Form 4
0
0
Jan 3
Form 4
-15.54%
-357.56K
1.94M
Nov 7
Form 4
-14.96%
-166.94K
$13.00
-$2,170,181.00
948.95K
Oct 14
Form 4
-18.14%
-247.31K
$13.00
-$3,215,082.00
1.12M
Oct 12
Form 4
0
0
Jan 3
Form 4
+169.64%
3.64M
$6.00
$2,499,996.00
5.79M
Oct 15
Form 3
0
0
No matching records found

CUTERA INC (CUTR) Snapshot price: $2.79

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-99.83%
-1.00M
1.74K
Feb 22
Form 4
1M
1M
Apr 5
Form 3
0
0
No matching records found

ANESIVA, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-6.04%
-404.65K
$0.09
-$37,146.87
6.29M
Jan 6
Form 4
0
0
May 9
Form 4
0
0
May 9
Form 4
0
0
Feb 6
Form 3
0
0
Form 3
0
0
Form 4
0
0
Jun 8 - Nov 10
Form 4
0
0
Jun 8
Form 4
2.1M
2.1M
Feb 18
Form 3
0
0
No matching records found